Transgenic mice can express mutant human coagulation factor IX with higher level of clotting activity

Biochemical Genetics

Volumn 44, Issue 7-8, 2006, Pages 347-358

  Yan, Jing Bin ^a   Wang, Shu ^a   Huang, Wen Ying ^a   Xiao, Yan Ping ^a   Ren, Zhao Rui ^a   Huang, Shu Zheng ^a   Zeng, Yi Tao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Expression; Human coagulation factor IX; Mutant; Transgenic mouse

Indexed keywords

ALANINE; ARGININE; BETA CASEIN; BLOOD CLOTTING FACTOR 9; COMPLEMENTARY DNA;

ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONCENTRATION (PARAMETERS); ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HISTOLOGY; INTRON; MALE; MAMMARY GLAND; MILK; MOLECULAR CLONING; MOUSE; MUTATION; NONHUMAN; PHYSIOLOGY; PLASMID; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALIA; CAPRA HIRCUS; MUS MUSCULUS;

EID: 33845873298     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-006-9034-1     Document Type: Article

References (24)

1. Archibald, A. L., McClenaghan, M., Hornsey, V., Simons, J. P., and Clark, A. J. (1990). High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 87:5178-5182.
2. Barash, I., Faerman, A., Baruch, A., Nathan, M., Hurwitz, D. R., and Shani, M. (1993). Synthesis and secretion of human serum albumin by mammary gland explants of virgin and lactating transgenic mice. Transgenic Res. 2:266-276.
3. Chang, J., Jin, J., Lollar, P., Bode, W., Brandstetter, H., Hamaguchi, N., Straight, D. L., and Stafford, D. W. (1998). Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity. J. Biol. Chem. 273:12089-12094.
4. Eyestone, W. H., and Campbell, K. H. (1999). Nuclear transfer from somatic cells: Applications in farm animal species. J. Reprod. Fertil. Suppl. 54:489-497.
5. Houdebine, L. M. (2000). Transgenic animal bioreactors. Transgenic Res. 9(4/5):305-320.
6. Huang, Y., Zhang, K. Z., Huang, W. Y., Lu, D. R., Huang, Y., Ma, Z. L., Ren, Z. R., Qiu, X. F., Xue, J. L., Zeng, Y. T., and Huang, S. Z. (1998). Expression of biologically active human clotting factor IX (hFIX) in the mammary gland of transgenic mice. Chin. Sci. Bull. 43(15):1294-1298.
7. Huang, Z., Yan, J. B., Huang, Y., Sun, Q., Xiao, Y. P., Huang, Y., and Zeng, Y. T. (2002). High expression of human FIX (hFIX) in transgenic mice directed by goat β-casein gene promoter. Acta Genet. Sin. 29:206-211.
8. Lubon, H. (1998). Transgenic animal bioreactors in biotechnology and production of blood proteins. Biotechnol. Annu. Rev. 4:1-54.
9. Matsuda, Y., Harada, Y. N., Natsuume-Sakai, S., Lee, K., Shiomi, T., and Chapman, V. M. (1992). Location of the mouse complement factor H gene (cfh) by FISH analysis and replication R-banding. Cytogenet. Cell. Genet. 61:282-285.
10. Meade, H., Gates, L., Lacy, E., and Lonberg, N. (1990). Bovine alpha S1-casein gene sequences direct high level expression of active human urokinase in mouse milk. Biotechnology (NY) 8:443-446.
11. Miao, C. X., Lu, G. X., Wang, Y. J., and Xie, Y. (1998). Mapping BNLF-1 transgene on transgenic mouse progeny chromosome by fluorescence in situ hybridization. Acta Genet. Sin. 25:422-426.
12. Mutucumarana, V. P., Duffy, E. J., Lollar, P., and Johnson, A. E. (1992). The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa: A fluorescence study. J. Biol. Chem. 267:17012-17021.
13. Nakanishi, T., Kuroiwa, A., Yamada, S., Isotani, A., Yamashita, A., Tairaka, A., Hayashi, T., Takagi, T., Ikawa, M., Matsuda, Y., and Okabe, M. (2002). FISH analysis of 142 EGFP transgene integration sites into the mouse genome. Genomics 80:564-574.
14. Niemann, H., and Kues, W. A. (2003). Application of transgenesis in livestock for agriculture and biomedicine. Anim. Reprod. Sci. 79:291-317.
15. Park, D. S., Lee, H., Riedel, C., Hulit, J., Scherer, P. E., Pestell, R. G., and Lisanti, M. P. (2001). Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism. J. Biol. Chem. 276:48389-48397.
16. Pittius, C. W., Hennighausen, L., Lee, E., Westphal, H., Nicols, E., Vitale, J., and Gordon, K. (1988). A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 85:5874-5878.
17. Sawyer, J. R., Moore, M. M., and Hozier, J. C. (1987). High resolution G-banded chromosomes of the mouse. Chromosoma (Berlin) 95:350-358.
18. Schnieke, A. E., Kind, A. J., Ritchie, W. A., Mycock, K., Scott, A. R., Ritchie, M., Wilmut, I., Colman, A., and Campbell, K. H. (1997). Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 278:2130-2133.
19. Schuettrumpf, J., Herzog, R. W., Schlachterman, A., Kaufhold, A., Stafford, D. W., and Arruda, V. R. (2005). Factor IX variants improve gene therapy efficacy for hemophilia B. Blood 105:2316-2323.
20. Van Cott, K. E., Butler, S. P., Russell, C. G., Subramanian, A., Lubon, H., Gwazdauskas, F. C., Knight, J., Drohan, W. N., and Velander, W. H. (1999). Transgenic pigs as bioreactors: A comparison of gamma-carboxylation of glutamic acid in recombinant human protein C and factor IX by the mammary gland. Genet. Anal. 15:155-160.
21. Wang, L., Nichols, T. C., Read, M. S., Bellinger, D. A., and Verma, I. M. (2000). Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol. Ther. 1:154-158.
22. Xiao, Y. P., Jiang, X. R., and Wang, R. L. (2003). Screening for DMD/BMD deletion carriers by fluorescence in situ hybridization. Genet. Testing 7:195-201.
23. Xiao, Y. P., Xi, Y., Huang, W. Y., and Huang, Y. (2002). Detection of the integration of human FIX (hFIX) on chromosome of transgenic mice by fluorescene in situ hybridization. Hereditas (China) 24:232-236.
24. Yull, F., Harold, G., Wallace, R., Cowper, A., Percy, J., Cottingham, I., and Clark, A. J. (1995). Fixing human factor IX (fIX): Correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 92:10899-10903.